+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033- Product Image
Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033- Product Image
New

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Grand View Research
  • ID: 5899476
Description Jump to:

Multiomics Market Growth & Trends

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights

  • Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
  • Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
  • Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
  • Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product & Service
1.2.2. Type
1.2.3. Platform
1.2.4. Application
1.2.5. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Multiomics Market: Product & Service Business Analysis
4.1. Segment Dashboard
4.2. Global Multiomics Market Product & Service Movement Analysis
4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Product
4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Instruments
4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Consumables
4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Software
4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Multiomics Market: Type Business Analysis
5.1. Segment Dashboard
5.2. Global Multiomics Market Type Movement Analysis
5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Single-cell Multiomics
5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Bulk Multiomics
5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Multiomics Market: Platform Business Analysis
6.1. Segment Dashboard
6.2. Global Multiomics Market Platform Movement Analysis
6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
6.4. Genomics
6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Transcriptomics
6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Proteomics
6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Metabolomics
6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Integrated Omics Platforms
6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Multiomics Market: Application Business Analysis
7.1. Segment Dashboard
7.2. Global Multiomics Market Application Movement Analysis
7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Cell Biology
7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Oncology
7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Neurology
7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Immunology
7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Multiomics Market: End-use Business Analysis
8.1. Segment Dashboard
8.2. Global Multiomics Market End-use Movement Analysis
8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
8.4. Academic and Research Institutes
8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Pharmaceutical & Biotechnology Companies
8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Others
8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Europe
9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Regulatory Framework
9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Competitive Scenario
9.4.9.3. Regulatory Framework
9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Regulatory Framework
9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Regulatory Framework
9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Regulatory Framework
9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. Regulatory Framework
9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. MEA
9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. Regulatory Framework
9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Regulatory Framework
9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. Regulatory Framework
9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Regulatory Framework
9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Participant’s Overview
10.4.1. BD
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Thermo Fisher Scientific Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Illumina, Inc
10.4.3.1. Overview
10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Danaher
10.4.4.1. Overview
10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. PerkinElmer Inc.
10.4.5.1. Overview
10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Shimadzu Corporation
10.4.6.1. Overview
10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Bruker
10.4.7.1. Overview
10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. QIAGEN
10.4.8.1. Overview
10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Agilent Technologies, Inc.
10.4.9.1. Overview
10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. BGI
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 4 Global multiomics market, by type, 2021 - 2033 (USD Million)
Table 5 Global multiomics market, by platform, 2021 - 2033 (USD Million)
Table 6 Global multiomics market, by application, 2021 - 2033 (USD Million)
Table 7 Global multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 8 Global multiomics market, by region, 2021 - 2033 (USD Million)
Table 9 North America multiomics market, by country, 2021 - 2033 (USD Million)
Table 10 North America multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 11 North America multiomics market, by type, 2021 - 2033 (USD Million)
Table 12 North America multiomics market, by platform, 2021 - 2033 (USD Million)
Table 13 North America multiomics market, by application, 2021 - 2033 (USD Million)
Table 14 North America multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 15 U.S. multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 16 U.S. multiomics market, by type, 2021 - 2033 (USD Million)
Table 17 U.S. multiomics market, by platform, 2021 - 2033 (USD Million)
Table 18 U.S. multiomics market, by application, 2021 - 2033 (USD Million)
Table 19 U.S. multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 20 Canada multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 21 Canada multiomics market, by type, 2021 - 2033 (USD Million)
Table 22 Canada multiomics market, by platform, 2021 - 2033 (USD Million)
Table 23 Canada multiomics market, by application, 2021 - 2033 (USD Million)
Table 24 Canada multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 25 Mexico multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 26 Mexico multiomics market, by type, 2021 - 2033 (USD Million)
Table 27 Mexico multiomics market, by platform, 2021 - 2033 (USD Million)
Table 28 Mexico multiomics market, by application, 2021 - 2033 (USD Million)
Table 29 Mexico multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 30 Europe multiomics market, by country, 2021 - 2033 (USD Million)
Table 31 Europe multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 32 Europe multiomics market, by type, 2021 - 2033 (USD Million)
Table 33 Europe multiomics market, by platform, 2021 - 2033 (USD Million)
Table 34 Europe multiomics market, by application, 2021 - 2033 (USD Million)
Table 35 Europe multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 36 UK multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 37 UK multiomics market, by type, 2021 - 2033 (USD Million)
Table 38 UK multiomics market, by platform, 2021 - 2033 (USD Million)
Table 39 UK multiomics market, by application, 2021 - 2033 (USD Million)
Table 40 UK multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 41 Germany multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 42 Germany multiomics market, by type, 2021 - 2033 (USD Million)
Table 43 Germany multiomics market, by platform, 2021 - 2033 (USD Million)
Table 44 Germany multiomics market, by application, 2021 - 2033 (USD Million)
Table 45 Germany multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 46 France multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 47 France multiomics market, by type, 2021 - 2033 (USD Million)
Table 48 France multiomics market, by platform, 2021 - 2033 (USD Million)
Table 49 France multiomics market, by application, 2021 - 2033 (USD Million)
Table 50 France multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 51 Italy multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 52 Italy multiomics market, by type, 2021 - 2033 (USD Million)
Table 53 Italy multiomics market, by platform, 2021 - 2033 (USD Million)
Table 54 Italy multiomics market, by application, 2021 - 2033 (USD Million)
Table 55 Italy multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 56 Spain multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 57 Spain multiomics market, by type, 2021 - 2033 (USD Million)
Table 58 Spain multiomics market, by platform, 2021 - 2033 (USD Million)
Table 59 Spain multiomics market, by application, 2021 - 2033 (USD Million)
Table 60 Spain multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 61 Denmark multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 62 Denmark multiomics market, by type, 2021 - 2033 (USD Million)
Table 63 Denmark multiomics market, by platform, 2021 - 2033 (USD Million)
Table 64 Denmark multiomics market, by application, 2021 - 2033 (USD Million)
Table 65 Denmark multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 66 Sweden multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 67 Sweden multiomics market, by type, 2021 - 2033 (USD Million)
Table 68 Sweden multiomics market, by platform, 2021 - 2033 (USD Million)
Table 69 Sweden multiomics market, by application, 2021 - 2033 (USD Million)
Table 70 Sweden multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 71 Norway multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 72 Norway multiomics market, by type, 2021 - 2033 (USD Million)
Table 73 Norway multiomics market, by platform, 2021 - 2033 (USD Million)
Table 74 Norway multiomics market, by application, 2021 - 2033 (USD Million)
Table 75 Norway multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 76 Asia Pacific multiomics market, by country, 2021 - 2033 (USD Million)
Table 77 Asia Pacific multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 78 Asia Pacific multiomics market, by type, 2021 - 2033 (USD Million)
Table 79 Asia Pacific multiomics market, by platform, 2021 - 2033 (USD Million)
Table 80 Asia Pacific multiomics market, by application, 2021 - 2033 (USD Million)
Table 81 Asia Pacific multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 82 Japan multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 83 Japan multiomics market, by type, 2021 - 2033 (USD Million)
Table 84 Japan multiomics market, by platform, 2021 - 2033 (USD Million)
Table 85 Japan multiomics market, by application, 2021 - 2033 (USD Million)
Table 86 Japan multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 87 China multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 88 China multiomics market, by type, 2021 - 2033 (USD Million)
Table 89 China multiomics market, by platform, 2021 - 2033 (USD Million)
Table 90 China multiomics market, by application, 2021 - 2033 (USD Million)
Table 91 China multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 92 India multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 93 India multiomics market, by type, 2021 - 2033 (USD Million)
Table 94 India multiomics market, by platform, 2021 - 2033 (USD Million)
Table 95 India multiomics market, by application, 2021 - 2033 (USD Million)
Table 96 India multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 97 Australia multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 98 Australia multiomics market, by type, 2021 - 2033 (USD Million)
Table 99 Australia multiomics market, by platform, 2021 - 2033 (USD Million)
Table 100 Australia multiomics market, by application, 2021 - 2033 (USD Million)
Table 101 Australia multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 102 Thailand multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 103 Thailand multiomics market, by type, 2021 - 2033 (USD Million)
Table 104 Thailand multiomics market, by platform, 2021 - 2033 (USD Million)
Table 105 Thailand multiomics market, by application, 2021 - 2033 (USD Million)
Table 106 Thailand multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 107 South Korea multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 108 South Korea multiomics market, by type, 2021 - 2033 (USD Million)
Table 109 South Korea multiomics market, by platform, 2021 - 2033 (USD Million)
Table 110 South Korea multiomics market, by application, 2021 - 2033 (USD Million)
Table 111 South Korea multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 112 Latin America multiomics market, by country, 2021 - 2033 (USD Million)
Table 113 Latin America multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 114 Latin America multiomics market, by type, 2021 - 2033 (USD Million)
Table 115 Latin America multiomics market, by platform, 2021 - 2033 (USD Million)
Table 116 Latin America multiomics market, by application, 2021 - 2033 (USD Million)
Table 117 Latin America multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 118 Brazil multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 119 Brazil multiomics market, by type, 2021 - 2033 (USD Million)
Table 120 Brazil multiomics market, by platform, 2021 - 2033 (USD Million)
Table 121 Brazil multiomics market, by application, 2021 - 2033 (USD Million)
Table 122 Brazil multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 123 Argentina multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 124 Argentina multiomics market, by type, 2021 - 2033 (USD Million)
Table 125 Argentina multiomics market, by platform, 2021 - 2033 (USD Million)
Table 126 Argentina multiomics market, by application, 2021 - 2033 (USD Million)
Table 127 Argentina multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 128 Middle East & Africa multiomics market, by country, 2021 - 2033 (USD Million)
Table 129 Middle East & Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 130 Middle East & Africa multiomics market, by type, 2021 - 2033 (USD Million)
Table 131 Middle East & Africa multiomics market, by platform, 2021 - 2033 (USD Million)
Table 132 Middle East & Africa multiomics market, by application, 2021 - 2033 (USD Million)
Table 133 Middle East & Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 134 South Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 135 South Africa multiomics market, by type, 2021 - 2033 (USD Million)
Table 136 South Africa multiomics market, by platform, 2021 - 2033 (USD Million)
Table 137 South Africa multiomics market, by application, 2021 - 2033 (USD Million)
Table 138 South Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia multiomics market, by type, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia multiomics market, by platform, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia multiomics market, by application, 2021 - 2033 (USD Million)
Table 143 Saudi Arabia multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 144 UAE multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 145 UAE multiomics market, by type, 2021 - 2033 (USD Million)
Table 146 UAE multiomics market, by platform, 2021 - 2033 (USD Million)
Table 147 UAE multiomics market, by application, 2021 - 2033 (USD Million)
Table 148 UAE multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 149 Kuwait multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 150 Kuwait multiomics market, by type, 2021 - 2033 (USD Million)
Table 151 Kuwait multiomics market, by platform, 2021 - 2033 (USD Million)
Table 152 Kuwait multiomics market, by application, 2021 - 2033 (USD Million)
Table 153 Kuwait multiomics market, by end-use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Multiomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Multiomics market driver analysis
Fig. 12 Multiomics market restraint analysis
Fig. 13 Multiomics market: Porter's analysis
Fig. 14 Multiomics market: PESTEL analysis
Fig. 15 Multiomics market: Product & service outlook and key takeaways
Fig. 16 Multiomics market: Product & service market share analysis, 2024 - 2033
Fig. 17 Global multiomics by products market, 2021 - 2033 (USD Million)
Fig. 18 Global multiomics by instruments market, 2021 - 2033 (USD Million)
Fig. 19 Global multiomics by consumables market, 2021 - 2033 (USD Million)
Fig. 20 Global multiomics by software market, 2021 - 2033 (USD Million)
Fig. 21 Global multiomics by services market, 2021 - 2033 (USD Million)
Fig. 22 Multiomics market: Type outlook and key takeaways
Fig. 23 Multiomics market: Type market share analysis, 2024 - 2033
Fig. 24 Global single-cell multiomics by men market, 2021 - 2033 (USD Million)
Fig. 25 Global multiomics by bulk multiomics market, 2021 - 2033 (USD Million)
Fig. 26 Multiomics market: Platform outlook and key takeaways
Fig. 27 Multiomics market: Platform market share analysis, 2024 - 2033
Fig. 28 Global multiomics by genomics market, 2021 - 2033 (USD Million)
Fig. 29 Global multiomics by transcriptomics market, 2021 - 2033 (USD Million)
Fig. 30 Global multiomics by proteomics market, 2021 - 2033 (USD Million)
Fig. 31 Global multiomics by metabolomics market, 2021 - 2033 (USD Million)
Fig. 32 Global multiomics by integrated omics platforms market, 2021 - 2033 (USD Million)
Fig. 33 Multiomics market: Application outlook and key takeaways
Fig. 34 Multiomics market: Application market share analysis, 2024 - 2033
Fig. 35 Global multiomics by cell biology market, 2021 - 2033 (USD Million)
Fig. 36 Global multiomics by oncology market, 2021 - 2033 (USD Million)
Fig. 37 Global multiomics by neurology market, 2021 - 2033 (USD Million)
Fig. 38 Global multiomics by immunology market, 2021 - 2033 (USD Million)
Fig. 39 Multiomics market: End-use outlook and key takeaways
Fig. 40 Multiomics market: End-use market share analysis, 2024 - 2033
Fig. 41 Global multiomics by academic and research institutes market, 2021 - 2033 (USD Million)
Fig. 42 Global multiomics by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 43 Global multiomics by others market, 2021 - 2033 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada multiomics market, 2021 - 2033 (USD Million)
Fig. 50 Europe multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 UK key country dynamics
Fig. 52 UK multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 Germany key country dynamics
Fig. 54 Germany multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 55 France key country dynamics
Fig. 56 France multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 67 Asia-Pacific multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 68 Japan key country dynamics
Fig. 69 Japan multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 70 China key country dynamics
Fig. 71 China multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 72 India key country dynamics
Fig. 73 India multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 74 Australia key country dynamics
Fig. 75 Australia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 76 Thailand key country dynamics
Fig. 77 Thailand multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 78 South Korea key country dynamics
Fig. 79 South Korea multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 80 Latin America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 83 Mexico key country dynamics
Fig. 84 Mexico multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 87 MEA multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 96 Key company categorization
Fig. 97 Company market positioning
Fig. 98 Market participant categorization
Fig. 99 Strategy framework

Companies Mentioned

  • BD
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc
  • Danaher (Beckman Coulter)
  • PerkinElmer, Inc
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI Genomics

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.72 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.81 Billion
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Multiomics Services Market Size, Share & Trends Analysis Report By Service (Research, Data Analysis), By Type (Single-cell Multiomics, Bulk Multiomics), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Multiomics Services Market Size, Share & Trends Analysis Report By Service (Research, Data Analysis), By Type (Single-cell Multiomics, Bulk Multiomics), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Single Cell Multiomics Market Report by Type, Product Type, Technique, Application, End User, and Region 2025-2033 - Product Image

Single Cell Multiomics Market Report by Type, Product Type, Technique, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Multiomics Market by Technology, Omics, Product Type, Application, End User - Global Forecast to 2030 - Product Image

Multiomics Market by Technology, Omics, Product Type, Application, End User - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Multiomics Market - Product Image

Multiomics Market

  • Report
  • 149 Pages
  • Global
From
Multiomics - Global Strategic Business Report - Product Image

Multiomics - Global Strategic Business Report

  • Report
  • 209 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.